High doses of favipiravir counter SARS-CoV-2 in hamsters, Hydroxychloroquine has no significant effect: Study
High doses of favipiravir counter SARS-CoV-2 in hamsters, Hydroxychloroquine has no significant effect: Study
newKerala.com
0 shares
1 views
You might like
Related news coverage
Hydroxychloroquine Doesn’t Counter SARS-CoV-2 In Hamsters, High Dose Of Favipiravir Does
Virologists at the KU Leuven Rega Institute have been working on two lines of SARS-CoV-2 research: searching for a vaccine to..
Eurasia Review
Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study
Virologists have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus..
Science Daily